NEW YORK (GenomeWeb News) – Genetics-based diagnostic company GigaGen today said that it has received four grants totaling more than $1 million to develop and validate its Cell-Seq technology to aid in the prediction of immune flares in transplant recipients and autoimmune patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.